Back

Amyloid beta, a marker of vascular aging and cardiovascular disease, is associated with accelerated progression of renal dysfunction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Secondary prevention: a multifactorial approach Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Evmorfia Aivalioti

National & Kapodistrian University of Athens Medical School, Athens (Greece)

9 More presentations in this session

Presentation thumbnail
Comprehensive risk factor management through a dedicated secondary prevention clinic: experience from hamilton, Ontario
Miss C. Frketich (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Variability of pre-test probability for obstructive coronary artery disease between referring primary care physicians and estimations from the referral letters
Mr E. Stertman (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Integrated care using the ABC-stroke pathway improves cardiovascular outcomes and survival in patients with recent ischaemic stroke: a population-based cohort study
Doctor S. Choi (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Long-term continuation to pharmacological treatment for secondary prevention after a myocardial infarction: a register study
Ms M. Sakalaki (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
National dispensing of evidence-based treatment for New Zealand patients before and after peripheral arterial or percutaneous coronary procedures; undertreatment in plain sight.
Associate Professor S. Wells (Auckland, NZ)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention: a multifactorial approach

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease
thumbnail
Congress Presentation
Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease
thumbnail
Congress Presentation
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources